MID-VOLUME · FEMALE-LED
desoximetasone Side Effects
desoximetasone (also sold as Topicort) sits MID-VOLUME #246 of 524 by FAERS report count. Lead signal: FEMALE-LED - 89% of sex-coded reports are female (13,565 F / 1,698 M). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 18,159
- FAERS reports
FDA Adverse Event Reporting System extract for desoximetasone. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
desoximetasone reporting skew - 89% of sex-coded reports are female (13,565 F / 1,698 M). Volume band MID-VOLUME #246 of 524 by FAERS report count; caseload WATCHLIST.
Mid-book FAERS page for desoximetasone (Topicort) (18,159 reports). Signature FEMALE-LED. Dominant age band on file: 18-44. Educational reference only.
Counts from the openFDA FAERS extract (2004–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED.
PAIN leads 8,816 of 18,159 reports
FEMALE-LED reporters · age peak 18-44
Female-led reporters (89% of sex-coded rows)
Age peak 18-44 (5,980 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (4,534 reports, 25.0%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| SYSTEMIC LUPUS ERYTHEMATOSUS | 2,085 |
| GLOSSODYNIA | 2,013 |
| TYPE 2 DIABETES MELLITUS | 2,008 |
| DUODENAL ULCER PERFORATION | 1,986 |
| HAND DEFORMITY | 1,968 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 1,945 |
| RHEUMATOID ARTHRITIS | 1,938 |
| PSORIATIC ARTHROPATHY | 1,935 |
| HELICOBACTER INFECTION | 1,932 |
| FIBROMYALGIA | 1,926 |
| SYNOVITIS | 1,891 |
| WOUND | 1,889 |
| FATIGUE | 1,879 |
| INFUSION RELATED REACTION | 1,874 |
| RASH | 1,874 |
| HYPOAESTHESIA | 1,862 |
| HEPATIC ENZYME INCREASED | 1,858 |
| PEMPHIGUS | 1,854 |
| HYPERTENSION | 1,852 |
| PERICARDITIS | 1,831 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (6,570, 36.2% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| FATIGUE | 3,117 |
| PAIN | 2,865 |
| RHEUMATOID ARTHRITIS | 2,863 |
| SYSTEMIC LUPUS ERYTHEMATOSUS | 2,851 |
| SWELLING | 2,775 |
| ARTHRALGIA | 2,771 |
| ABDOMINAL DISCOMFORT | 2,765 |
| RASH | 2,744 |
| ALOPECIA | 2,731 |
| SYNOVITIS | 2,725 |
| HAND DEFORMITY | 2,624 |
| PEMPHIGUS | 2,605 |
| GLOSSODYNIA | 2,604 |
| JOINT SWELLING | 2,595 |
| PERICARDITIS | 2,583 |
| ARTHROPATHY | 2,553 |
| HYPERSENSITIVITY | 2,552 |
| DUODENAL ULCER PERFORATION | 2,517 |
How to read desoximetasone FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 18,159 voluntary reports linked to desoximetasone (Topicort), 2004-2025. Death is listed on 4,534 (25.0%). Hospitalization appears on 6,570 (36.2%). Top co-reported indication: Product Used For Unknown Indication.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 89% of sex-coded reports are female (13,565 F / 1,698 M).
Read with desoximetasone
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 18,237 FAERS cases (Δ 78 heavier vs desoximetasone); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED.
ABS(total_reports) peer at 18,056 FAERS cases (Δ 103 lighter vs desoximetasone); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED.
ABS(total_reports) peer at 17,976 FAERS cases (Δ 183 lighter vs desoximetasone); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED.
ABS(total_reports) peer at 17,969 FAERS cases (Δ 190 lighter vs desoximetasone); DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 37.1 pp vs desoximetasone's DEATH-HEAVY): CASELOAD · HOSP-MID.
desoximetasone stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.